Peter B. Dirks
Researcher Next ID · RN-033017
Researcher · Biochemistry, Genetics and Molecular Biology
Toronto, Canada
- Works count
- 829
- Citation count
- 46,372
- H-index
- 84
- i10-index
- 219
Research interests
Publications
Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity
Nature Cancer · 2021 · https://doi.org/10.1038/s43018-020-00154-9
GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
Nature Communications · 2020 · https://doi.org/10.1038/s41467-020-18020-8
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas
Cancer Cell · 2020 · https://doi.org/10.1016/j.ccell.2020.03.011
Childhood cerebellar tumours mirror conserved fetal transcriptional programs
Nature · 2019 · https://doi.org/10.1038/s41586-019-1158-7
Stalled developmental programs at the root of pediatric brain tumors
Nature Genetics · 2019 · https://doi.org/10.1038/s41588-019-0531-7
A Feedforward Mechanism Mediated by Mechanosensitive Ion Channel PIEZO1 and Tissue Mechanics Promotes Glioma Aggression
Neuron · 2018 · https://doi.org/10.1016/j.neuron.2018.09.046
DNA hypermethylation within TERT promoter upregulates TERT expression in cancer
Journal of Clinical Investigation · 2018 · https://doi.org/10.1172/jci121303
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Cancer Cell · 2017 · https://doi.org/10.1016/j.ccell.2017.05.005
Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy
Nature · 2017 · https://doi.org/10.1038/nature23666
Comprehensive Analysis of Hypermutation in Human Cancer
Cell · 2017 · https://doi.org/10.1016/j.cell.2017.09.048
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2016.71.8726
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2016.66.6552
BRAF Mutation and CDKN2A Deletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma
Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2014.58.3922
Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers
Nature Genetics · 2015 · https://doi.org/10.1038/ng.3202
High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
Cell · 2015 · https://doi.org/10.1016/j.cell.2015.11.015
Quiescent Sox2+ Cells Drive Hierarchical Growth and Relapse in Sonic Hedgehog Subgroup Medulloblastoma
Cancer Cell · 2014 · https://doi.org/10.1016/j.ccr.2014.05.005
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
Nature · 2014 · https://doi.org/10.1038/nature13108
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
The Lancet Oncology · 2013 · https://doi.org/10.1016/s1470-2045(13)70110-4
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Nature · 2012 · https://doi.org/10.1038/nature11327
Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells
Cancer Research · 2006 · https://doi.org/10.1158/0008-5472.can-06-3126
Identification of human brain tumour initiating cells
Nature · 2004 · https://doi.org/10.1038/nature03128
Identification of a cancer stem cell in human brain tumors.
PubMed · 2003
Current projects
No projects listed.